Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation (Multiple Sclerosis and Demyelinating Disorders (2017) 2 (1) DOI: 10.1186/s40893-017-0020-8)

Beatriz Moreno; Gemma Vila; Begoña Fernandez-Diez; Raquel Vázquez; Alessandra di Penta; Oihana Errea; Nagore Escala; Andrés Miguez; Jordi Alberch; Pablo Villoslada

ArticleOPEN ACCESS

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation (Multiple Sclerosis and Demyelinating Disorders (2017) 2 (1) DOI: 10.1186/s40893-017-0020-8)

Multiple Sclerosis and Demyelinating Disorders

DOI: 10.1186/s40893-019-0040-7

0Citations

2Readers

Abstract

After publication of the article [1], it has been brought to our attention that the full funding acknowledgement is missing from the original article. It should also include the following –“This work was supported by the Instituto de Salud Carlos III with FEDER funds (Otra forma de hacer Europa) from the European Commission (FIS: PI12/01823)”.

Cite

CITATION STYLE

APA

Moreno, B., Vila, G., Fernandez-Diez, B., Vázquez, R., di Penta, A., Errea, O., … Villoslada, P. (2019, April 23). Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation (Multiple Sclerosis and Demyelinating Disorders (2017) 2 (1) DOI: 10.1186/s40893-017-0020-8). Multiple Sclerosis and Demyelinating Disorders. BioMed Central Ltd. https://doi.org/10.1186/s40893-019-0040-7

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation (Multiple Sclerosis and Demyelinating Disorders (2017) 2 (1) DOI: 10.1186/s40893-017-0020-8)

Abstract

Cite

Register to see more suggestions